Elevated Cardiac Troponin in Acute Stroke without Acute Coronary Syndrome Predicts Long-Term Adverse Cardiovascular Outcomes

Table 2

Incidence of adverse outcomes during postdischarge follow-up.

Variable	Normal cTnI (%)	Elevated cTnI (%)	value
Nonfatal MI	3.3	41.2	0.0001
MACE	14.2	41.2	0.01
Death from any cause	14.5	41.2	0.017
Death from cardiovascular cause	0.5	5.9	0.163
CABG	1.1	0.0	0.837
Revascularization^*	10.9	5.9	0.445
Rehospitalizations	53.6	35.3	0.205
Restroke	10.9	5.9	0.445

MI: myocardial infarction. MACE: major adverse cardiac events. CABG: coronary artery bypass graft.
^*Revascularization during postdischarge follow-up due to new cardiac events.